X

About this post

Source
Author
Date
10:00 AM | February 11, 2013
Language
English
Categories
URL
Link to this page


Citation
RNL BIO CO LTD  announced a couple of days ago that it has applied to the Korean Food and Drug Administration (KFDA) an application to receive approval for phase II and phase III human clinical trials, involving their stem cell therapy for people suffering from cerebral palsy. Purpose of the study is to examine the safety of the drug, called Astrostem, over a period of 11 months.The trial will be conducted at the Kyung Hee University Hospital at Gangdong and the Bethesda Hospital and a […]

Ra, J., Shin, I., Kim, S., Kang, S., Kang, B., Lee, H., Kim, Y., Jo, J., Yoon, E., Choi, H. & Kwon, E. (2011). Safety of Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells in Animals and Humans, Stem Cells and Development, 20 (8) 1297-1308. DOI:

Tags

Comments

Log in to leave a comment